Drugs / DS107E
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03676933 | Oct 2015 → Apr 2016 | atopic eczema | DS Biopharma | Completed | No outcome recorded |
| Phase 2 | NCT03676036 | Jun 2015 → Mar 2018 | atopic eczema | DS Biopharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS107E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03676036 ↗ |
| Route | Topical | “DS107E taken topically twice a day” NCT03676036 ↗ |